Lupin gains on launching combination drugs for heart failure patients

Lupin gains on launching combination drugs for heart failure patients

by 5paisa Research Team Last Updated: Jan 19, 2023 - 09:30 am 3.6k Views
Listen icon

Today, the stock opened at Rs 753.00 and has touched a high and low of Rs 769.70 and Rs 753.00, respectively.

On Wednesday, shares of Lupin closed at Rs 766.90, up by 13.85 points or 1.84% from its previous closing of Rs 753.05 on the BSE.

Lupin has launched combination drugs Sacubitril and Valsartan under two brand names, Valentas and Arnipin, in India. This drug combination is indicated for patients with Heart Failure (HF) conditions. Valentas and Arnipin tablets are available in 200 mg, 100 mg, and 50 mg. Valentas and Arnipin are indicated to reduce repeated hospitalization and the risk of cardiovascular death among adult patients with chronic mild to moderate heart failure.

Commenting on the launch, Rajeev Sibal, President – India Region Formulations, Lupin said, “Heart failure is a difficult condition with severe unmet needs, necessitating the development of treatment agents to improve patient outcomes. As a leader in the cardiac therapy area, Lupin is committed to offering patients with treatment options that limit the need for hospitalization and reduce the risk of death. The launch of Valentas and Arnipin aligns with this commitment and offers patients an important treatment option and fulfils an unmet need while reducing the cost of therapy.” 

Lupin is an innovation-led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

The BSE group 'A' stock of face value of Rs 2 has a 52-week high and low of Rs 969.00 and Rs 583.05. Last one week high and low of the scrip stood at Rs 769.70 and Rs 745.15, respectively. The current market cap of the company is Rs 34,875.59 crore.

The promoters holding in the company stood at 47.10%, while Institutions and Non-Institutions held 43.36% and 9.53% respectively.

Share Market Today

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage


About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Open Free Demat Account
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest News
Revving Up: Catch the Exciting November 2023 Auto Sales Highlights!

Escorts Kubota Ltd. witnessed a 4% increase in its total dispatches to dealerships, reaching 8,258 units, reflecting a 3.7% YoY growth. The rise in total dispatches to dealerships for Escorts Kubota Ltd.

Dixon Technologies to Manufacture Xiaomi Phones at Noida Plant

In a transformative move to enhance local smartphone manufacturing, Dixon Technologies (India) Ltd. has inaugurated a smartphone manufacturing plant in Noida.

JSW Group acquires 35% in MG Motor India, a SAIC subsidiary

On November 30, JSW Group announced a joint venture (JV) with SAIC Motor Corp. Ltd, the parent company of MG Motor India.